Search

Lei Yao

Examiner (ID: 12775, Phone: (571)272-3112 , Office: P/1642 )

Most Active Art Unit
1642
Art Unit(s)
1642
Total Applications
1328
Issued Applications
662
Pending Applications
127
Abandoned Applications
552

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 8159119 [patent_doc_number] => 20120100558 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-26 [patent_title] => 'LUNG CANCER DIAGNOSIS' [patent_app_type] => utility [patent_app_number] => 13/062929 [patent_app_country] => US [patent_app_date] => 2009-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16382 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20120100558.pdf [firstpage_image] =>[orig_patent_app_number] => 13062929 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/062929
LUNG CANCER DIAGNOSIS Aug 26, 2009 Abandoned
Array ( [id] => 6599623 [patent_doc_number] => 20100098626 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'PROTEIN' [patent_app_type] => utility [patent_app_number] => 12/547736 [patent_app_country] => US [patent_app_date] => 2009-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 38441 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12547736 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/547736
Protein Aug 25, 2009 Issued
Array ( [id] => 6599652 [patent_doc_number] => 20100098627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/547743 [patent_app_country] => US [patent_app_date] => 2009-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 36639 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20100098627.pdf [firstpage_image] =>[orig_patent_app_number] => 12547743 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/547743
PROTEINS Aug 25, 2009 Abandoned
Array ( [id] => 6348372 [patent_doc_number] => 20100021441 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'MHC MOLECULE-BINDING TUMOR-ASSOCIATED PEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/544117 [patent_app_country] => US [patent_app_date] => 2009-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13876 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20100021441.pdf [firstpage_image] =>[orig_patent_app_number] => 12544117 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/544117
MHC molecule-binding tumor-associated peptides Aug 18, 2009 Issued
Array ( [id] => 6585506 [patent_doc_number] => 20100047868 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'Tumour Suppressor Protein' [patent_app_type] => utility [patent_app_number] => 12/537050 [patent_app_country] => US [patent_app_date] => 2009-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 8734 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20100047868.pdf [firstpage_image] =>[orig_patent_app_number] => 12537050 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/537050
Tumour Suppressor Protein Aug 5, 2009 Abandoned
Array ( [id] => 6257909 [patent_doc_number] => 20100029748 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'Metastasis Promoting Genes and Proteins' [patent_app_type] => utility [patent_app_number] => 12/535583 [patent_app_country] => US [patent_app_date] => 2009-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 15431 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20100029748.pdf [firstpage_image] =>[orig_patent_app_number] => 12535583 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/535583
Metastasis Promoting Genes and Proteins Aug 3, 2009 Abandoned
Array ( [id] => 7811160 [patent_doc_number] => 08133690 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-13 [patent_title] => 'Method for inhibiting the formation of SET1 family core complexes' [patent_app_type] => utility [patent_app_number] => 12/509874 [patent_app_country] => US [patent_app_date] => 2009-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 21 [patent_no_of_words] => 6756 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 190 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/133/08133690.pdf [firstpage_image] =>[orig_patent_app_number] => 12509874 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/509874
Method for inhibiting the formation of SET1 family core complexes Jul 26, 2009 Issued
Array ( [id] => 6149251 [patent_doc_number] => 20110020846 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'Oral cancer biomarker and inspection method using the same' [patent_app_type] => utility [patent_app_number] => 12/460656 [patent_app_country] => US [patent_app_date] => 2009-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10187 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20110020846.pdf [firstpage_image] =>[orig_patent_app_number] => 12460656 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/460656
Oral cancer biomarker and inspection method using the same Jul 21, 2009 Abandoned
Array ( [id] => 6526662 [patent_doc_number] => 20100015045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'Cancerous Disease Modifying Antibodies' [patent_app_type] => utility [patent_app_number] => 12/504473 [patent_app_country] => US [patent_app_date] => 2009-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13365 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20100015045.pdf [firstpage_image] =>[orig_patent_app_number] => 12504473 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/504473
Cancerous Disease Modifying Antibodies Jul 15, 2009 Abandoned
Array ( [id] => 5367107 [patent_doc_number] => 20090304666 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'CONJUGATE FOR THE SPECIFIC TARGETING OF ANTICANCER AGENTS TO TUMOR CELLS OR TUMOR VASCULATURE AND PRODUCTION THEREOF' [patent_app_type] => utility [patent_app_number] => 12/502011 [patent_app_country] => US [patent_app_date] => 2009-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 22556 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0304/20090304666.pdf [firstpage_image] =>[orig_patent_app_number] => 12502011 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/502011
CONJUGATE FOR THE SPECIFIC TARGETING OF ANTICANCER AGENTS TO TUMOR CELLS OR TUMOR VASCULATURE AND PRODUCTION THEREOF Jul 12, 2009 Abandoned
Array ( [id] => 5944081 [patent_doc_number] => 20110104701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'PROTEIN DISULFIDE ISOMERASE ASSAY METHOD FOR THE IN VITRO DIAGNOSIS OF COLORECTAL CANCER' [patent_app_type] => utility [patent_app_number] => 12/999242 [patent_app_country] => US [patent_app_date] => 2009-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 26917 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20110104701.pdf [firstpage_image] =>[orig_patent_app_number] => 12999242 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/999242
Protein disulfide isomerase assay method for the in vitro diagnosis of colorectal cancer Jul 8, 2009 Issued
Array ( [id] => 8282478 [patent_doc_number] => 08216578 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-10 [patent_title] => 'Antibodies to oncostatin M receptor' [patent_app_type] => utility [patent_app_number] => 12/497439 [patent_app_country] => US [patent_app_date] => 2009-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 24372 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12497439 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/497439
Antibodies to oncostatin M receptor Jul 1, 2009 Issued
Array ( [id] => 5551842 [patent_doc_number] => 20090285828 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'Anti-PECAM Therapy for Metastasis Suppression' [patent_app_type] => utility [patent_app_number] => 12/497011 [patent_app_country] => US [patent_app_date] => 2009-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11273 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20090285828.pdf [firstpage_image] =>[orig_patent_app_number] => 12497011 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/497011
Anti-PECAM Therapy for Metastasis Suppression Jul 1, 2009 Abandoned
Array ( [id] => 6348785 [patent_doc_number] => 20100021482 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'NOVEL DEATH ASSOCIATED PROTEINS, AND THAP1 AND PAR4 PATHWAYS IN APOPTOSIS CONTROL' [patent_app_type] => utility [patent_app_number] => 12/482790 [patent_app_country] => US [patent_app_date] => 2009-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 88049 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20100021482.pdf [firstpage_image] =>[orig_patent_app_number] => 12482790 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/482790
NOVEL DEATH ASSOCIATED PROTEINS, AND THAP1 AND PAR4 PATHWAYS IN APOPTOSIS CONTROL Jun 10, 2009 Abandoned
Array ( [id] => 8220789 [patent_doc_number] => 20120134995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-31 [patent_title] => 'METHOD FOR PREDICTING THE THERAPEUTIC RESPONSEIVENESS OF A PATIENT TO A MEDICAL TREATMENT WITH AN EGFR INHIBITOR' [patent_app_type] => utility [patent_app_number] => 13/320299 [patent_app_country] => US [patent_app_date] => 2009-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10012 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13320299 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/320299
METHOD FOR PREDICTING THE THERAPEUTIC RESPONSEIVENESS OF A PATIENT TO A MEDICAL TREATMENT WITH AN EGFR INHIBITOR May 14, 2009 Abandoned
Array ( [id] => 5367132 [patent_doc_number] => 20090304691 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'ANTAGONISTS OF BMP9, BMP10, ALK1 AND OTHER ALK1 LIGANDS, AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/467170 [patent_app_country] => US [patent_app_date] => 2009-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 23597 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0304/20090304691.pdf [firstpage_image] =>[orig_patent_app_number] => 12467170 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/467170
Antagonists of BMP9, BMP10, ALK1 and other ALK1 ligands, and uses thereof May 14, 2009 Issued
Array ( [id] => 5558279 [patent_doc_number] => 20090269856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'METHODS AND COMPOSITIONS FOR EVALUATING BREAST CANCER PROGNOSIS' [patent_app_type] => utility [patent_app_number] => 12/466149 [patent_app_country] => US [patent_app_date] => 2009-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 26646 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20090269856.pdf [firstpage_image] =>[orig_patent_app_number] => 12466149 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/466149
METHODS AND COMPOSITIONS FOR EVALUATING BREAST CANCER PROGNOSIS May 13, 2009 Abandoned
Array ( [id] => 7685988 [patent_doc_number] => 20100120153 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'N-GLYCOSYLATION MUTANT OF MELANOMA DIFFERENTIATION ASSOCIATED GENE-7' [patent_app_type] => utility [patent_app_number] => 12/434387 [patent_app_country] => US [patent_app_date] => 2009-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10144 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120153.pdf [firstpage_image] =>[orig_patent_app_number] => 12434387 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/434387
N-GLYCOSYLATION MUTANT OF MELANOMA DIFFERENTIATION ASSOCIATED GENE-7 Apr 30, 2009 Abandoned
Array ( [id] => 5302892 [patent_doc_number] => 20090297544 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'NOVEL TUMOR ANTIGEN PROTEIN SART-3 AND TUMOR ANTIGEN PEPTIDES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/432700 [patent_app_country] => US [patent_app_date] => 2009-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17885 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20090297544.pdf [firstpage_image] =>[orig_patent_app_number] => 12432700 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/432700
Tumor antigen protein SART-3 and tumor antigen peptides thereof Apr 28, 2009 Issued
Array ( [id] => 6220595 [patent_doc_number] => 20100055690 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'PROGNOSTIC BIOMARKERS IN PATIENTS WITH OVARIAN CANCER' [patent_app_type] => utility [patent_app_number] => 12/422530 [patent_app_country] => US [patent_app_date] => 2009-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 22128 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20100055690.pdf [firstpage_image] =>[orig_patent_app_number] => 12422530 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/422530
PROGNOSTIC BIOMARKERS IN PATIENTS WITH OVARIAN CANCER Apr 12, 2009 Abandoned
Menu